thioridazine has been researched along with Staphylococcal Infections in 9 studies
Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the efficacy of conservative systemic treatment with dicloxacillin (DCX) in combination with TDZ (DCX+TDZ), compared to DCX alone, against early APVGI caused by methicillin-sensitive Staphylococcus aureus (MSSA) in a porcine model." | 1.46 | Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity. ( Andersen, TE; Behr-Rasmussen, C; Grønnemose, RB; Klein, K; Klitgaard, JK; Kolmos, HJ; Lindholt, JS; Stenger, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Rampacci, E | 1 |
| Felicetti, T | 1 |
| Pietrella, D | 1 |
| Sabatini, S | 1 |
| Passamonti, F | 1 |
| Luan, W | 1 |
| Liu, X | 1 |
| Wang, X | 1 |
| An, Y | 1 |
| Wang, Y | 1 |
| Wang, C | 1 |
| Shen, K | 1 |
| Xu, H | 1 |
| Li, S | 1 |
| Liu, M | 1 |
| Yu, LU | 1 |
| Poulsen, MØ | 2 |
| Schøler, L | 1 |
| Nielsen, A | 1 |
| Skov, MN | 2 |
| Kolmos, HJ | 5 |
| Kallipolitis, BH | 2 |
| Olsen, A | 1 |
| Klitgaard, JK | 5 |
| Stenger, M | 3 |
| Hendel, K | 1 |
| Bollen, P | 1 |
| Licht, PB | 1 |
| Klein, K | 2 |
| Grønnemose, RB | 2 |
| Lindholt, JS | 2 |
| Alm, M | 1 |
| Thomsen, P | 1 |
| Andersen, TE | 2 |
| Rasmussen, KS | 1 |
| Jacobsen, K | 1 |
| Behr-Rasmussen, C | 1 |
| Amaral, L | 1 |
| Viveiros, M | 1 |
| Kristiansen, JE | 1 |
| Toth, J | 1 |
1 review available for thioridazine and Staphylococcal Infections
| Article | Year |
|---|---|
"Non-Antibiotics": alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries.
Topics: Developing Countries; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aure | 2006 |
8 other studies available for thioridazine and Staphylococcal Infections
| Article | Year |
|---|---|
Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; | 2022 |
Inhibition of Drug Resistance of
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriolysis; beta-Lactams; Cloxacillin; Drug Resistance | 2019 |
Combination therapy with thioridazine and dicloxacillin combats meticillin-resistant Staphylococcus aureus infection in Caenorhabditis elegans.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Caenorhabditis elegans; Dicloxacillin; Disease Model | 2014 |
Assessments of Thioridazine as a Helper Compound to Dicloxacillin against Methicillin-Resistant Staphylococcus aureus: In Vivo Trials in a Mouse Peritonitis Model.
Topics: Animals; Anti-Bacterial Agents; Dicloxacillin; Disease Models, Animal; Doublecortin Protein; Female; | 2015 |
Co-release of dicloxacillin and thioridazine from catheter material containing an interpenetrating polymer network for inhibiting device-associated Staphylococcus aureus infection.
Topics: Anti-Bacterial Agents; Catheter-Related Infections; Cross Infection; Dicloxacillin; Drug Delivery Sy | 2016 |
Combination of thioridazine and dicloxacillin as a possible treatment strategy of staphylococci.
Topics: Anti-Bacterial Agents; Dicloxacillin; Dopamine Antagonists; Drug Synergism; Humans; Microbial Sensit | 2017 |
Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity.
Topics: Animals; Body Temperature; Body Weight; Dicloxacillin; Disease Models, Animal; Drug Synergism; Femal | 2017 |
[Agranulocytosis following prolonged treatment with Mellaril].
Topics: Adult; Agranulocytosis; Female; Humans; Staphylococcal Infections; Thioridazine; Time Factors | 1979 |